Clinical Trial: A Phase 1 Study of GZC8072 Tablets Following a Single Dose in Healthy Study Participants and Multiple Doses in Obese/Overweight Study Participants

U.S., Aug. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07784699) titled 'A Phase 1 Study of GZC8072 Tablets Following a Single Dose in Healthy Study Participants and Multiple Doses in Obese/Overweight Study Participants' on Aug. 21.

Brief Summary: This trial is conducted in China. This study plans to include 2 parts, i.e., a single-dose study and a multiple-dose study:

The single-dose study will be conducted in healthy adult participants to evaluate the safety, tolerability, and pharmacokinetic profile of single doses of GZC8072 Tablets; The multiple-dose study will be conducted in obese or overweight study participants to evaluate the safety, tolerability, pharmacokinetic and pharmacodynamic profiles o...